Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry.

Journal: International Journal Of Stroke : Official Journal Of The International Stroke Society
Published:
Abstract

Background: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. Aim: To summarize the findings of a multinational observational cohort of patients with SARS-CoV-2 and cerebrovascular disease.

Methods: Retrospective observational cohort of consecutive adults evaluated in the emergency department and/or admitted with coronavirus disease 2019 (COVID-19) across 31 hospitals in four countries (1 February 2020-16 June 2020). The primary outcome was the incidence rate of cerebrovascular events, inclusive of acute ischemic stroke, intracranial hemorrhages (ICH), and cortical vein and/or sinus thrombosis (CVST).

Results: Of the 14,483 patients with laboratory-confirmed SARS-CoV-2, 172 were diagnosed with an acute cerebrovascular event (1.13% of cohort; 1130/100,000 patients, 95%CI 970-1320/100,000), 68/171 (40.5%) were female and 96/172 (55.8%) were between the ages 60 and 79 years. Of these, 156 had acute ischemic stroke (1.08%; 1080/100,000 95%CI 920-1260/100,000), 28 ICH (0.19%; 190/100,000 95%CI 130-280/100,000), and 3 with CVST (0.02%; 20/100,000, 95%CI 4-60/100,000). The in-hospital mortality rate for SARS-CoV-2-associated stroke was 38.1% and for ICH 58.3%. After adjusting for clustering by site and age, baseline stroke severity, and all predictors of in-hospital mortality found in univariate regression (p < 0.1: male sex, tobacco use, arrival by emergency medical services, lower platelet and lymphocyte counts, and intracranial occlusion), cryptogenic stroke mechanism (aOR 5.01, 95%CI 1.63-15.44, p < 0.01), older age (aOR 1.78, 95%CI 1.07-2.94, p = 0.03), and lower lymphocyte count on admission (aOR 0.58, 95%CI 0.34-0.98, p = 0.04) were the only independent predictors of mortality among patients with stroke and COVID-19.

Conclusions: COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke. The mortality rate is high for COVID-19-associated cerebrovascular complications; therefore, aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.

Authors
James Siegler, Pere Cardona, Juan Arenillas, Blanca Talavera, Ana Guillen, Alba Chavarría Miranda, Mercedes De Lera, Priyank Khandelwal, Ivo Bach, Pratit Patel, Amit Singla, Manuel Requena, Marc Ribo, Dinesh Jillella, Srikant Rangaraju, Raul Nogueira, Diogo Haussen, Alejandro Vazquez, Xabier Urra, Ángel Chamorro, Luis Román, Jesse Thon, Ryna Then, Emma Sanborn, Natalia De La Ossa, Mònica Millàn, Isaac Ruiz, Ossama Mansour, Mohammed Megahed, Cristina Tiu, Elena Terecoasa, Răzvan Radu, Thanh Nguyen, Gioacchino Curiale, Artem Kaliaev, Alexandra Czap, Jacob Sebaugh, Alicia Zha, David Liebeskind, Santiago Ortega Gutierrez, Mudassir Farooqui, Ameer Hassan, Laurie Preston, Mary Patterson, Saif Bushnaq, Osama Zaidat, Tudor Jovin

Similar Publications